tiprankstipranks
Valion Bio (VBIO)
NASDAQ:VBIO
US Market
VBIO
Valion Bio
RESEARCH TOOLSreports
Want to see VBIO full AI Analyst Report?

Valion Bio (VBIO) Ratios

165 Followers

Valion Bio Ratios

VBIO's free cash flow for Q4 2026 was $0.00. For the 2026 fiscal year, VBIO's free cash flow was decreased by $ and operating cash flow was $0.00. See a summary of the company’s cash flow.
Ratios
TTM
Mar 22Mar 20Mar 19Mar 18
Liquidity Ratios
Current Ratio
 0.57 11.72 1.17 4.55 ―
Quick Ratio
 0.57 11.37 0.99 3.83 ―
Cash Ratio
 0.32 10.64 0.82 3.54 ―
Solvency Ratio
 0.18 -4.80 -1.34 -6.35 ―
Operating Cash Flow Ratio
 -0.11 -4.60 -2.37 -5.62 ―
Short-Term Operating Cash Flow Coverage
 -0.86 0.00 -84.08 0.00 ―
Net Current Asset Value
$ -83.57M$ 12.53M$ -1.21M$ 2.32M$ ―
Leverage Ratios
Debt-to-Assets Ratio
 0.01 0.05 0.96 0.00 ―
Debt-to-Equity Ratio
 0.09 0.05 -1.25 0.00 ―
Debt-to-Capital Ratio
 0.08 0.05 5.03 0.00 ―
Long-Term Debt-to-Capital Ratio
 0.06 0.00 5.60 0.00 ―
Financial Leverage Ratio
 5.99 1.13 -1.30 1.28 ―
Debt Service Coverage Ratio
 22.77 -3.65 -6.99 -8.35 ―
Interest Coverage Ratio
 -15.23 -3.09 -7.57 -8.22 ―
Debt to Market Cap
 0.04 0.00 <0.01 0.00 ―
Interest Debt Per Share
 0.02 72.46 82.15 19.26 ―
Net Debt to EBITDA
 0.03 1.85 -0.13 0.62 ―
Profitability Margins
Gross Profit Margin
25.75%-11.06%-26.16%-68.81%―
EBIT Margin
316.90%-572.13%-373.95%-881.67%―
EBITDA Margin
403.10%-570.07%-373.02%-880.71%―
Operating Profit Margin
-75.92%-483.02%-372.56%-867.38%―
Pretax Profit Margin
311.92%-728.39%-423.14%-987.14%―
Net Profit Margin
311.28%-728.47%-423.14%-987.62%―
Continuous Operations Profit Margin
311.92%-728.47%-423.14%-987.62%―
Net Income Per EBT
99.79%100.01%100.00%100.05%―
EBT Per EBIT
-410.87%150.80%113.58%113.81%―
Return on Assets (ROA)
10.03%-56.49%-237.69%-137.17%―
Return on Equity (ROE)
91.35%-64.00%309.18%-174.95%―
Return on Capital Employed (ROCE)
-2.53%-40.76%-1251.56%-153.65%―
Return on Invested Capital (ROIC)
-2.52%-40.29%-1097.26%-153.65%―
Return on Tangible Assets
27.22%-56.49%-237.69%-137.17%―
Earnings Yield
28.43%-3.69%-1.79%-2.04%―
Efficiency Ratios
Receivables Turnover
 4.14 12.67 16.54 32.31 ―
Payables Turnover
 2.17 1.64 2.93 1.92 ―
Inventory Turnover
 0.00 3.02 4.50 1.49 ―
Fixed Asset Turnover
 0.09 1.67 45.26 15.56 ―
Asset Turnover
 0.03 0.08 0.56 0.14 ―
Working Capital Turnover Ratio
 -2.96 0.18 0.68 0.00 ―
Cash Conversion Cycle
 -79.72 -72.67 -21.33 65.87 ―
Days of Sales Outstanding
 88.23 28.80 22.07 11.30 ―
Days of Inventory Outstanding
 0.00 120.92 81.07 244.53 ―
Days of Payables Outstanding
 167.96 222.38 124.47 189.96 ―
Operating Cycle
 88.23 149.71 103.14 255.83 ―
Cash Flow Ratios
Operating Cash Flow Per Share
 >-0.01 -160.65 -131.43 -159.57 ―
Free Cash Flow Per Share
 >-0.01 -160.65 -131.43 -160.92 ―
CapEx Per Share
 <0.01 0.00 0.00 1.35 ―
Free Cash Flow to Operating Cash Flow
 1.00 1.00 1.00 1.01 ―
Dividend Paid and CapEx Coverage Ratio
 -312.71 0.00 0.00 -118.39 ―
Capital Expenditure Coverage Ratio
 -312.71 0.00 0.00 -118.39 ―
Operating Cash Flow Coverage Ratio
 -0.24 -7.93 -2.06 0.00 ―
Operating Cash Flow to Sales Ratio
 -0.11 -4.81 -3.52 -8.74 ―
Free Cash Flow Yield
-1.00%-2.44%-1.49%-1.82%―
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 3.68 -27.13 -55.84 -48.92 ―
Price-to-Sales (P/S) Ratio
 11.53 197.61 236.29 483.14 ―
Price-to-Book (P/B) Ratio
 2.21 17.36 -172.65 85.58 ―
Price-to-Free Cash Flow (P/FCF) Ratio
 -105.00 -41.06 -67.13 -54.83 ―
Price-to-Operating Cash Flow Ratio
 -104.43 -41.06 -67.13 -55.29 ―
Price-to-Earnings Growth (PEG) Ratio
 <0.01 -0.73 30.07 0.00 ―
Price-to-Fair Value
 2.21 17.36 -172.65 85.58 ―
Enterprise Value Multiple
 2.89 -32.82 -63.48 -54.23 ―
Enterprise Value
 43.85M 218.14M 203.64M 200.61M ―
EV to EBITDA
 2.77 -32.82 -63.48 -54.23 ―
EV to Sales
 11.16 187.09 236.79 477.64 ―
EV to Free Cash Flow
 -101.59 -38.87 -67.27 -54.20 ―
EV to Operating Cash Flow
 -101.77 -38.87 -67.27 -54.66 ―
Tangible Book Value Per Share
 -0.36 379.94 -51.10 103.09 ―
Shareholders’ Equity Per Share
 0.18 379.94 -51.10 103.09 ―
Tax and Other Ratios
Effective Tax Rate
 0.00 >-0.01 0.00 >-0.01 ―
Revenue Per Share
 0.03 33.38 37.34 18.26 ―
Net Income Per Share
 0.11 -243.16 -158.00 -180.36 ―
Tax Burden
 1.00 1.00 1.00 1.00 ―
Interest Burden
 0.98 1.27 1.13 1.12 ―
Research & Development to Revenue
 0.00 0.75 0.77 2.36 ―
SG&A to Revenue
 0.53 2.51 1.18 2.79 ―
Stock-Based Compensation to Revenue
 0.08 0.05 0.09 0.02 ―
Income Quality
 -0.04 0.66 0.83 0.88 ―
Currency in USD